Regulatory and clinical roadblocks have set back its oral BTK inhibitor tolebrutinib, but the drug class still has many ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.

The research has generated significant interest from firms in food & supplements as consumers seek natural alternatives to ...

Adenosine deaminase acting on RNA (ADAR) is the enzyme responsible for adenosine-to-inosine (A-to-I) RNA editing, a process ...

Researchers have discovered that mimicking cold exposure or fasting can trigger an immune response in the body that slows ...

Tarun Kapoor is tackling a deceptively tricky biochemical challenge: how to speed up the internal machinery of living cells.

Madrigal Pharmaceuticals MDGL has acquired exclusive global rights to ervogastat from Pfizer PFE, strengthening its pipeline ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the ...

Improving Global Outcomes recommendations reduced moderate or severe AKI risk after major surgery, according to data ...